文献速递生殖医学

2019冠状病毒病后早发性卵巢功能不全:自身免疫性促卵泡激素及促卵泡激素受体阻断

Premature Ovarian Insufficiency After Coronavirus Disease 2019 (COVID-19): Autoimmune Follicle-Stimulating Hormone (FSH) and FSH Receptor Blockade.
PubMed 文献 · Obstet Gynecol · 2024-04-05

报告3例30-37岁患者在接种疫苗前轻症或无症状COVID-19后出现自身免疫性卵巢低反应,其中2例对最大剂量促性腺激素无反应,经泼尼松30 mg治疗一个月后FSH正常并获得成功体外受精。所有患者抗苗勒管激素高于平均水平。

要点

  • 接种前COVID-19可能通过自身抗体导致罕见自身免疫性卵巢低反应
  • 2例患者泼尼松30 mg治疗一个月后FSH正常且获成功体外受精
  • 所有患者抗苗勒管激素高于平均水平并持续存在于临床卵巢功能不全期间

核心结论

  • 接种疫苗前对COVID-19产生的自身抗体可能是自身免疫性卵巢低反应的罕见原因。
  • 疫苗接种可能具有保护作用,但需进一步研究评估疫苗接种的影响及自身免疫性FSH或FSH受体阻断的持续时间。

研究设计与样本

  • 病例报告,报告3例年龄30-37岁、接种疫苗前有轻症或无症状COVID-19且核苷酸抗体确认的患者。

主要发现

  • 2例患者对最大剂量促性腺激素超过4周无反应,尽管在COVID-19前有反应史。
  • 这2例患者经泼尼松30 mg治疗一个月后FSH水平正常,在成功的体外受精周期中获得高卵母细胞产量和囊胚形成。
  • 所有3例患者抗苗勒管激素水平高于平均水平,并在临床卵巢功能不全期间持续存在。
  • 2例患者FSH水平升高,可能源于FSH受体阻断。
  • 1例患者有对每日75国际单位促性腺激素高反应史且FSH水平低于正常,对每日525国际单位促性腺激素超过一个月无卵巢反应,提示自身免疫性FSH糖蛋白阻断和可能的FSH受体阻断。

局限性

  • 需进一步研究评估疫苗接种的影响及自身免疫性FSH或FSH受体阻断的持续时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since the onset of the coronavirus disease (COVID-19) pandemic, a variety of long-COVID-19 symptoms and autoimmune complications have been recognized. CASES: We report three cases of autoimmune premature poor ovarian response in patients aged 30-37 years after mild to asymptomatic COVID-19 before vaccination, with nucleotide antibody confirmation. Two patients failed to respond to maximum-dose gonadotropins for more than 4 weeks, despite a recent history of response before having COVID-19. After a month of prednisone 30 mg, these two patients had normal follicle-stimulating hormone (FSH) levels, high oocyte yield, and blastocyst formation in successful in vitro fertilization cycles. All three patients have above-average anti-müllerian hormone levels that persisted throughout their clinical ovarian insufficiency. Two patients had elevated FSH levels, perhaps resulting from FSH receptor blockade. One patient, with a history of high response to gonadotropins 75 international units per day and below-normal FSH levels, had no ovarian response to more than a month of gonadotropins (525 international units daily), suggesting autoimmune block of the FSH glycoprotein and possible FSH receptor blockade. CONCLUSION: Auto-antibody production in response to COVID-19 before vaccination may be a rare cause of autoimmune poor ovarian response. Although vaccination is likely protective, further study will be required to evaluate the effect of vaccination and duration of autoimmune FSH or FSH receptor blockade.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Stern R, Bibi M, Keltz MD, et al. Premature Ovarian Insufficiency After Coronavirus Disease 2019 (COVID-19): Autoimmune Follicle-Stimulating Hormone (FSH) and FSH Receptor Blockade. Obstet Gynecol. 2024. PMID: 38574363. doi:10.1097/AOG.0000000000005574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。